Global Phage Therapy Market Overview And Scope:
Global Phage Therapy Market Size was estimated at USD 37.74 million in 2022 and is projected to reach USD 100.71 million by 2028, exhibiting a CAGR of 17.78% during the forecast period.
The Global Phage Therapy Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Phage Therapy utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage, Adaptive Phage Therapeutics, TechnoPhage
Global Phage Therapy Market Segmentation
By Type, Phage Therapy market has been segmented into:DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
By Application, Phage Therapy market has been segmented into:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Phage Therapy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Phage Therapy market.
Top Key Players Covered in Phage Therapy market are:
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences
Inc
Pharmex Group
LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International
Inc.
MicroMir
iNtODEWORLD
Inc.
NEXTBIOTICS
Armata Pharmaceuticals
Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Objective to buy this Report:
1. Phage Therapy analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Phage Therapy market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Phage Therapy Market by Type
5.1 Phage Therapy Market Overview Snapshot and Growth Engine
5.2 Phage Therapy Market Overview
5.3 DsDNA Bacteriophage
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 DsDNA Bacteriophage: Geographic Segmentation
5.4 SsDNA Bacteriophage
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 SsDNA Bacteriophage: Geographic Segmentation
5.5 SsRNA Bacteriophage
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 SsRNA Bacteriophage: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Phage Therapy Market by Application
6.1 Phage Therapy Market Overview Snapshot and Growth Engine
6.2 Phage Therapy Market Overview
6.3 Animal Health
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Animal Health: Geographic Segmentation
6.4 Aquaculture
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Aquaculture: Geographic Segmentation
6.5 Agriculture
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Agriculture: Geographic Segmentation
6.6 Food Industry
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Food Industry: Geographic Segmentation
6.7 Human Health
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Human Health: Geographic Segmentation
6.8 Others
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2017-2032F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Phage Therapy Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Phage Therapy Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Phage Therapy Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 NPO MICROGEN
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 PROTEON PHARMACEUTICALS
7.4 PHAGELUX
7.5 INTRALYTIX
7.6 MICREOS
7.7 ELIAVA BIOPREPARATIONS
7.8 LOCUS BIOSCIENCES
7.9 INC
7.10 PHARMEX GROUP
7.11 LLC
7.12 PHERECYDES PHARMA
7.13 APS BIOCONTROL LTD. (APS)
7.14 QINGDAO PHAGEPHARM BIO-TECH
7.15 FIXED-PHAGE LIMITED
7.16 ZEPTOMETRIX
7.17 PHAGE INTERNATIONAL
7.18 INC.
7.19 MICROMIR
7.20 INTODEWORLD
7.21 INC.
7.22 NEXTBIOTICS
7.23 ARMATA PHARMACEUTICALS
7.24 INC.
7.25 INNOPHAGE
7.26 ADAPTIVE PHAGE THERAPEUTICS
7.27 TECHNOPHAGE
Chapter 8: Global Phage Therapy Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 DsDNA Bacteriophage
8.2.2 SsDNA Bacteriophage
8.2.3 SsRNA Bacteriophage
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Animal Health
8.3.2 Aquaculture
8.3.3 Agriculture
8.3.4 Food Industry
8.3.5 Human Health
8.3.6 Others
Chapter 9: North America Phage Therapy Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 DsDNA Bacteriophage
9.4.2 SsDNA Bacteriophage
9.4.3 SsRNA Bacteriophage
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Animal Health
9.5.2 Aquaculture
9.5.3 Agriculture
9.5.4 Food Industry
9.5.5 Human Health
9.5.6 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Phage Therapy Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 DsDNA Bacteriophage
10.4.2 SsDNA Bacteriophage
10.4.3 SsRNA Bacteriophage
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Animal Health
10.5.2 Aquaculture
10.5.3 Agriculture
10.5.4 Food Industry
10.5.5 Human Health
10.5.6 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Phage Therapy Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 DsDNA Bacteriophage
11.4.2 SsDNA Bacteriophage
11.4.3 SsRNA Bacteriophage
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Animal Health
11.5.2 Aquaculture
11.5.3 Agriculture
11.5.4 Food Industry
11.5.5 Human Health
11.5.6 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Phage Therapy Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 DsDNA Bacteriophage
12.4.2 SsDNA Bacteriophage
12.4.3 SsRNA Bacteriophage
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Animal Health
12.5.2 Aquaculture
12.5.3 Agriculture
12.5.4 Food Industry
12.5.5 Human Health
12.5.6 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Phage Therapy Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 DsDNA Bacteriophage
13.4.2 SsDNA Bacteriophage
13.4.3 SsRNA Bacteriophage
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Animal Health
13.5.2 Aquaculture
13.5.3 Agriculture
13.5.4 Food Industry
13.5.5 Human Health
13.5.6 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Phage Therapy Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 DsDNA Bacteriophage
14.4.2 SsDNA Bacteriophage
14.4.3 SsRNA Bacteriophage
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Animal Health
14.5.2 Aquaculture
14.5.3 Agriculture
14.5.4 Food Industry
14.5.5 Human Health
14.5.6 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Phage Therapy Scope:
|
Report Data
|
Phage Therapy Market
|
|
Phage Therapy Market Size in 2025
|
USD XX million
|
|
Phage Therapy CAGR 2025 - 2032
|
XX%
|
|
Phage Therapy Base Year
|
2024
|
|
Phage Therapy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage, Adaptive Phage Therapeutics, TechnoPhage.
|
|
Key Segments
|
By Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
By Applications
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
|
